EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity

Hemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, Getiye Dejenu Kibret, Jennifer Arnold, Tremeur Guillaumie, Wajiha Jurdi Kheir, Gerhard Kok, Stela Vujosevic, Louise O'Toole, Els Mangelschots, Nandor Jaross und 9 weitere

Ophthalmology Retina · 2024

DOI: 10.1016/j.oret.2024.04.008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Hemal Mehta und 20 weiteren Autor:innen. Beteiligte Einrichtung: The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia; Department of Ophthal…. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Angiogenesis Inhibitors, Intravitreal Injections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, Royal Australian and New Zealand College of Ophthalmologists, Macular Disease Foundation Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaDiabetic RetinopathyAngiogenesis InhibitorsIntravitreal InjectionsVisual AcuityRegistriesVascular Endothelial Growth Factor ATomography, Optical CoherenceRanibizumabHumansMaleFemaleMiddle AgedFollow-Up StudiesTreatment OutcomeAgedBevacizumabReceptors, Vascular Endothelial Growth FactorTime FactorsRetrospective StudiesRecombinant Fusion Proteins

Stichwörter der Autor:innen

Anti-VEGFDiabetic macular edemaPro re nataReal-world evidenceTreat-and-extend

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ARanibizumabBevacizumabReceptors, Vascular Endothelial Growth FactorafliberceptRecombinant Fusion Proteins

Autor:innen und Institutionen

  • The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia; Department of Ophthalmology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia; Department of Ophthalmology, Dijon University Hospital, Dijon, France. Electronic address:…
  • The University of Sydney, Sydney Medical School, Discipline of Ophthalmology, Save Sight Institute, New South Wales, Australia.
  • Marsden Eye Specialists, Sydney, New South Wales, Australia.
  • Department of Ophthalmology, Saint Brieuc Hospital, Saint Brieuc, France.
  • Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.

Förderung

  • Bayer
  • Royal Australian and New Zealand College of Ophthalmologists
  • Macular Disease Foundation Australia
  • Novartis
  • National Health and Medical Research Council
  • Roche

Zitieren

APA

Mehta, H., Gabrielle, P. H., Hashimoto, Y., Kibret, G. D., Arnold, J., Guillaumie, T., Kheir, W. J., Kok, G., Vujosevic, S., O'Toole, L., Mangelschots, E., Jaross, N., Ceklic, L., Daien, V., Viola, F., Squirrell, D., Lavid, F. J., Creuzot-Garcher, C., Barthelmes, D., …, & Fight Retinal Blindness! Study Group (2024). One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.04.008

Vancouver

Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, et al. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.04.008

BibTeX
@article{Mehta2024,
  author = {Mehta, Hemal and Gabrielle, Pierre-Henry and Hashimoto, Yohei and Kibret, Getiye Dejenu and Arnold, Jennifer and Guillaumie, Tremeur and Kheir, Wajiha Jurdi and Kok, Gerhard and Vujosevic, Stela and O'Toole, Louise and Mangelschots, Els and Jaross, Nandor and Ceklic, Lala and Daien, Vincent and Viola, Francesco and Squirrell, David and Lavid, Francisco Javier and Creuzot-Garcher, Catherine and Barthelmes, Daniel and Gillies, Mark and Fight Retinal Blindness! Study Group, Fight Retinal Blindness! Study Group},
  title = {One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity},
  journal = {Ophthalmology Retina},
  year = {2024},
  doi = {10.1016/j.oret.2024.04.008}
}
Kostenlos starten →